source
- Patients struggle to opt out of MyChart data sharing, facing notary and endless hurdlesAn opinion piece highlights how MyChart users who want to stop sharing their health information encounter a maze of requirements. The author describes needing a notary, multiple phone calls, unansw…
- FDA launches rare disease framework initiativeA new initiative from the US Food and Drug Administration (FDA) aims to develop “an optimized, fit-for-purpose” framework to facilitate the development and marketing of treatments for rare diseases…raps · 1mo ago↗ source
- Verastem reports robust response in pancreatic cancer subgroup where Revolution's drug lagged